Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.

The Journal of infectious diseases - 1 Feb 2007

Flandre Philippe, Chappey Colombe, Marcelin Anne Genevieve, Ryan Kirk, Maa Jen-Fue, Bates Mike, Seekins Daniel, Bernard Marie Charlotte, Calvez Vincent, Molina Jean Michel

Abstract excerpt

OBJECTIVE: We investigated the relationship between human immunodeficiency virus (HIV) phenotypic susceptibility to didanosine and the antiviral activity of didanosine (ddI) in the JAGUAR study. METHODS: Baseline plasma HIV phenotypic susceptibility to ddI was assessed using a phenotype assay of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Didanosine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to Endpoint Determination

Share to HIV Infections

Share to Viral Load

Source

Identifiers

PMID: 17205478
DOI: 10.1086/510754

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17205478-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.PMID 17205478Read ↗

Clinically relevant genotype interpretation of resistance to didanosine.Semantic proximity Read ↗

Phenotypic susceptibility and virological outcome in nucleoside-experienced patients receiving three or four antiretroviral drugs.Semantic proximity Read ↗

Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets.Semantic proximity Read ↗

Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1.Semantic proximity Read ↗

An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.Semantic proximity Read ↗

Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.Semantic proximity Read ↗

Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.Semantic proximity Read ↗

Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with didanosine.Semantic proximity Read ↗

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.Semantic proximity Read ↗

Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutations.Semantic proximity Read ↗

Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial.Semantic proximity Read ↗

Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.